By adopting data as the backbone of the company and overhauling entire business models across the lifecycle, some pharma companies are beginning to identify trends and opportunities before payers and regulators, before physicians, and before even their own colleagues who haven’t yet got access.
At this meeting, speakers from Sanofi, Novartis, GSK and more will share their experiences of Real-World Evidence (RWE) and data-led methodology and explain how your company can gather, share and analyse real world data in order to make greater, more accurate predictions into the patient world of tomorrow.
FIND OUT MORE HERE
Key learnings will be:
- Win over payers with flawless RWE value execution
- Discover RWE’s place in your organisation and unlock its true strategic potential
- Predict future patient trends to meet payer needs and create long-term partnerships
- Maximise your data’s value – communicate your real world looking glass across departments
- Illuminate the patient journey to demonstrate why you’re the answer to market needs
For more information contact: Jmackintosh@eyeforpharma.com or visit us here.
Ryan co-runs Aspire Scientific, a dynamic, forward-thinking medical writing agency. Ryan has a passion for innovation, science and ethical communication.